Cargando…

15. Is Certolizumab a better option in treatment of psoriatic patients with active joint and skin involvement?

Detalles Bibliográficos
Autores principales:	McVey, Aoife, Rahiman, Imna Fazel, Chiu, Yeeho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	A. POSTER CASE REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652631/ http://dx.doi.org/10.1093/rap/rkx006

Ejemplares similares

Profile of certolizumab and its potential in the treatment of psoriatic arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2013)

Renal sarcoidosis associated with certolizumab pegol treatment for psoriatic arthritis
por: Hum, Ryan M, et al.
Publicado: (2022)

Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
por: Dattola, Annunziata, et al.
Publicado: (2017)

An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
por: Acosta-Felquer, María Laura, et al.
Publicado: (2016)

Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
por: Dattola, Annunziata, et al.
Publicado: (2017)

Successful Use of Certolizumab Pegol for Refractory Psoriatic Arthritis Triggered by COVID-19 Infection
por: Ohmura, Shin-ichiro, et al.
Publicado: (2021)

EP19 Renal sarcoidosis associated with certolizumab pegol treatment for psoriatic arthritis: a case report
por: Hum, Ryan Malcolm, et al.
Publicado: (2020)

MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population Survey
por: Tillett, William, et al.
Publicado: (2020)

Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposure
por: Mease, P, et al.
Publicado: (2015)

Early Disease Activity or Clinical Response as Predictors of Long‐Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis
por: van der Heijde, D., et al.
Publicado: (2017)

Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry
por: Mease, Philip J, et al.
Publicado: (2019)

The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature
por: Rutkowski, David, et al.
Publicado: (2019)

Certolizumab to treat hidradenitis suppurativa
por: Shadid, Asem, et al.
Publicado: (2022)

Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis
por: Hynnekleiv, Leif, et al.
Publicado: (2020)

4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
por: van der Heijde, Désirée, et al.
Publicado: (2018)

Psoriatic arthritis: prospects for the future
por: Hackett, Simon, et al.
Publicado: (2022)

Ultrasound shows swollen joints are the better proxy for synovitis than tender joints in DMARD-naïve early psoriatic arthritis
por: Dubash, Sayam R, et al.
Publicado: (2021)

5. Certolizumab Pegol for RA in pregnancy
por: Thorne, Iona, et al.
Publicado: (2017)

Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
Publicado: (2018)

The Involvement of Temporomandibular Joint in Psoriatic Arthritis: A Report of a Rare Case
por: R, Roopa, et al.
Publicado: (2021)

Translational Research Studies Unraveling the Origins of Psoriatic Arthritis: Moving Beyond Skin and Joints
por: Bolt, Janne W., et al.
Publicado: (2021)

Certolizumab in the long-term treatment of rheumatoid arthritis
por: Khan, Abdul, et al.
Publicado: (2011)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
por: Baysal, Mehmet, et al.
Publicado: (2018)

Improvement of Certolizumab Fab′ properties by PASylation technology
por: Mazaheri, Somayeh, et al.
Publicado: (2020)

Current treatment options for psoriatic arthritis: spotlight on abatacept
por: Ursini, Francesco, et al.
Publicado: (2018)

Cerebro-Spinal Meningitis
por: McVey,
Publicado: (1864)

Effect of Certolizumab Pegol on Multiple Facets of Psoriatic Arthritis as Reported by Patients: 24-Week Patient-Reported Outcome Results of a Phase III, Multicenter Study
por: Gladman, D, et al.
Publicado: (2014)

Psoriatic Arthritis: What is Happening at the Joint?
por: Belasco, Jennifer, et al.
Publicado: (2019)

Clinical Symptoms of Skin, Nails, and Joints Manifest Independently in Patients with Concomitant Psoriasis and Psoriatic Arthritis
por: Wittkowski, Knut M., et al.
Publicado: (2011)

Corrigendum: Translational Research Studies Unraveling the Origins of Psoriatic Arthritis: Moving Beyond Skin and Joints
por: Bolt, Janne W., et al.
Publicado: (2021)

Post-hoc analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis
por: Takeuchi, Tsutomu, et al.
Publicado: (2016)

Ustekinumab for the treatment of psoriatic arthritis: an update
por: Davari, Parastoo, et al.
Publicado: (2014)

Active axial spondyloarthritis: potential role of certolizumab pegol
por: Ranatunga, Sriya, et al.
Publicado: (2014)

Achievement of more stringent disease control is associated with reduced burden on workplace and household productivity: results from long-term certolizumab pegol treatment in patients with psoriatic arthritis
por: Tillett, William, et al.
Publicado: (2022)

Excel 5 para Windows : paso a paso
por: McVey, Sharel
Publicado: (1994)

Nail involvement in psoriatic arthritis
por: Sobolewski, Piotr, et al.
Publicado: (2017)

Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
por: Mease, Philip, et al.
Publicado: (2016)

Skin Cancer Correlations in Psoriatic Patients
por: Costache, Daniel Octavian, et al.
Publicado: (2023)

Doing better and being better in breast cancer care: an interview with Funmi Olopade
por: Olopade, Olufunmilayo I.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h12pctedh3mibt56ln0fe3itqi